Documentation, Drug Pricing and Independent Pharmacies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Documentation

Drug Pricing

Independent Pharmacies

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). This includes collecting data on utilization management practices, formulary changes, and patient experiences.

Drug Pricing

Drug Pricing Insurance Coverage and Processing Labelling HIPAA

The Lilly Digest

Ramblings of a pharmacist

FEBRUARY 16, 2022

The survey attempts to account for the differences in financial reports between pharmacies by asking specific questions about the major points of contention in accounting practices (how do you categorize your rebates? The NCPA Digest reports that the GDR for independent pharmacies was only 86% for 2020.”

Independent Pharmacies

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling

Pharmacist Digest

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

The Lilly Digest

Stay Connected